Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence hosted by Paul Sweeney, Scarlet Fu, and John Tucker
-Dan Ives, Global Head of Technology Research at Wedbush Securities, discusses OpenAI becoming the third major artificial intelligence developer to confidentially file for a public listing, joining rivals in an IPO pipeline. The company is working with Goldman Sachs Group Inc. and Morgan Stanley on a potential listing as soon as the fall, according to people familiar with the matter.
-Carmen Arroyo, Bloomberg Tech Reporter, discusses the Bloomberg Big Take story: “SpaceX IPO Forces Investors to Bet on Musk’s Entangled AI Empire.” Elon Musk’s imperial approach has made it difficult to decipher his companies’ true valuations. With the SpaceX IPO looming, some investors have raised concerns about SpaceX’s accounting practices, corporate governance risks and related-party transactions with other Musk entities. And as Musk aims for the stars, some investors have grown anxious about whether his goals are attainable, or if he’s bending the rules to pursue them.
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in biotech sector. Eli Lilly & Co. presented data showing its next-generation shot, retatrutide, can help patients lose 30% of their body weight over about two years.
-Jennifer Rie, Bloomberg Intelligence Senior Litigation Analyst, discusses Britain’s merger watchdog opening a probe into Paramount Skydance Corp.’s $110 billion takeover of Warner Bros. Discovery Inc. The Competition and Markets Authority has set an initial deadline of August 7 to rule on the deal, which would unite two Hollywood studios and major news networks.
See omnystudio.com/listener for privacy information.